Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
SLCB050 is an inhibitor that blocks the AIMP2 splice variant (DX2) from interacting with CDKN2A (p14/ARF), thereby possibly resulting in repression of tumor growth and apoptosis (PMID: 27302160).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Doxorubicin + SLCB050||Doxorubicin SLCB050||0||0|